TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare
TG Therapeutics, Inc. Long Term Debt 2016–2025
TG Therapeutics, Inc. annual/quarterly long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- TG Therapeutics, Inc. long term debt for the quarter ending December 31, 2025 were 245.6M, a 0.50% increase year-over-year.
- TG Therapeutics, Inc. long term debt for 2025 were 245.6M, a 0.50% increase from 2024.
- TG Therapeutics, Inc. long term debt for 2024 were 244.4M, a 143.45% increase from 2023.
- TG Therapeutics, Inc. long term debt for 2023 were 100.4M, a 41.14% increase from 2022.
- TG Therapeutics, Inc. long term debt for 2022 were 71.1M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| TG Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $246 |
| 2024 | $244 |
| 2023 | $100 |
| 2022 | $71 |
| 2021 | $68 |
| 2020 | $30 |
| 2019 | $29 |
| TG Therapeutics, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $246 |
| 2024-12-31 | $244 |
| 2023-12-31 | $100 |
| 2022-12-31 | $71 |
| 2021-12-31 | $68 |
| 2020-12-31 | $30 |
| 2019-12-31 | $29 |
TG Therapeutics, Inc. Long Term Debt — FAQ
TG Therapeutics, Inc. (TGTX) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TGTX's long term debt history?
The chart and table above show TG Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.